PTAB not a ‘death squad’ for drug patents: report

15-06-2017

PTAB not a ‘death squad’ for drug patents: report

vladimirsorokin / iStockphoto.com

The Patent Trial and Appeal Board (PTAB) is not a “death squad” for drug patents, according to a study conducted by Fitzpatrick, Cella, Harper & Scinto.


Patent Trial and Appeal Board, PTAB, drug patents, patent, inter partes review, Orange Book, biologics, Fitzpatrick, Cella, Harper & Scinto


LSIPR